Sranan Gold Corp. (CSE:SRAN)

MorphoSys AG Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	1.71	0	0.02	0.33	0.16
Cash & Short-Term Investments	1.71	0	0.02	0.33	0.16
Cash Growth	95984.83%	-67.87%	-95.38%	103.10%	-
Other Receivables	0.01	0	0.01	0.01	0.01
Receivables	0.01	0	0.01	0.01	0.01
Total Current Assets	1.93	0.01	0.02	0.34	0.17
Property, Plant & Equipment	3.93	0	0	0.14	0.13
Total Assets	5.86	0.01	0.02	0.48	0.3
Accounts Payable	0.01	0.01	0	0.05	0.06
Accrued Expenses	0.02	0.02	0.02	0.03	0.01
Total Current Liabilities	0.04	0.04	0.02	0.08	0.08
Long-Term Deferred Tax Liabilities	-	-	-	-	0.02
Total Liabilities	0.04	0.04	0.02	0.08	0.09
Common Stock	6.75	0.6	0.6	0.6	0.26
Retained Earnings	-1	-0.71	-0.68	-0.24	-0.08
Comprehensive Income & Other	0.08	0.08	0.08	0.04	0.02
Shareholders' Equity	5.83	-0.03	-0	0.4	0.2
Total Liabilities & Equity	5.86	0.01	0.02	0.48	0.3
Net Cash (Debt)	1.71	0	0.02	0.33	0.16
Net Cash Growth	95984.83%	-67.87%	-95.38%	103.10%	-
Net Cash Per Share	0.08	0.00	0.00	0.03	0.02
Filing Date Shares Outstanding	38.82	32.82	14.33	14.33	10.1
Total Common Shares Outstanding	38.82	14.33	14.33	14.33	10.1
Working Capital	1.9	-0.03	-0	0.25	0.09
Book Value Per Share	0.15	-0.00	-0.00	0.03	0.02
Tangible Book Value	5.83	-0.03	-0	0.4	0.2
Tangible Book Value Per Share	0.15	-0.00	-0.00	0.03	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.